Jakafi XR is Approved by the FDA for Myelofibrosis

The announcement on May 1st, 2026, that Jakafi XR has been approved by the FDA for patients managing myelofibrosis offers a new dosing option. Prior to this announcement, Jakafi (also sold in some countries with brand name Jakavi) was widely used in treatment of this and other conditions,, but had to be prescribed off-label. Now […]

More About Gastrointestinal Stromal Tumors (GIST)

A gastrointestinal stromal tumor (GIST) is a rare form of cancer that starts in the digestive tract. It typically develops in the stomach or small intestine. In older adults, especially those over 60, early symptoms can go unnoticed or be mistaken for less serious issues. GISTs grow from special cells in the digestive tract called interstitial cells […]

National Cancer Survivors Day

The first Sunday in June marks a special celebration close to many people’s hearts, National Cancer Survivors Day. Falling on June 1st in 2025, it is an annual event dedicated to offering inspiration for those recently diagnosed, support for families, and a gathering of survivors. Living with cancer can feel like running a difficult race […]

How Person-Centered Care Changed My Family’s Cancer Journey

Cancer affects millions of people in many different ways, but it does not define who they are. The new World Cancer Day campaign for 2025-27, “United by Unique,” focuses on putting people at the center of care. Over these three years, the plan is to move from raising awareness about people-centered care to taking action […]

IsraelPharm’s newest chemotherapy drugs – 85% Discounted Price!

We are happy to announce that we have been able to add a wide range of advanced drugs that are specially designed to treat various forms of cancers. These chemotherapies can now be purchased from IsraelPharm at far lower prices than the standard cost in US pharmacies – at an average discount of nearly 85%. […]